| abstract |
The compounds of Formula I are useful for the inhibition of CHK1 and / or CHK2. Methods for using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof are also disclosed, for diagnosis, prevention or in vitro, in situ and in vivo treatment of said disorders in mammalian cells, or associated pathological conditions. (see formula). |